Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bachir Sakr, MD
Women & Infants' Hospital of Rhode Island
Principal Investigator - Melanie Royce, MD
University of New Mexico Cancer Center
Principal Investigator - William Sikov, MD
Lifespan Hospitals
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Lifespan Hospitals
Providence, Rhode Island, United States
- Women & Infants' Hospital
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 31 Mar 2012
- Completion
- 31 Jan 2014
- Last update posted
- 9 Apr 2019
- Registered enrollment
- 18
- Registry id
- NCT00462865
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.